Related Experiment Videos
Inhibition of human complement components by Loxosceles reclusa venom.
Summary
Brown recluse spider venom inactivates early human complement components (C1-C7) in vitro. This occurs via the classical pathway, independent of the alternative pathway or most serum cofactors.
Area of Science:
- Immunology
- Toxicology
- Biochemistry
Background:
- The complement system is crucial for innate and adaptive immunity.
- Brown recluse spider venom (Loxosceles reclusa) is known for its cytotoxic effects.
- The interaction between spider venom and the human complement system is not fully understood.
Purpose of the Study:
- To investigate the effect of brown recluse spider venom on the human complement system in vitro.
- To determine which complement components are affected by the venom.
- To elucidate the mechanism and conditions of venom-induced complement inactivation.
Main Methods:
- Incubation of brown recluse spider venom with fresh human serum, cord serum, and purified complement components (C1-C7).
- Assay of complement component activity after venom exposure.
- Testing inactivation in serum depleted of Factor B to assess the role of the alternative pathway.
- Determination of optimal incubation temperatures (25-37°C) and times (30-60 min).
Main Results:
- Brown recluse spider venom inactivated human complement components C1 through C7 in vitro.
- Inactivation occurred in various human serum types and with purified complement components.
- The alternative complement pathway was not involved in the venom's action.
- Venom-induced inactivation required minimal serum cofactors, with potential minor involvement for C2.
Conclusions:
- Brown recluse spider venom directly targets and inactivates early components of the classical human complement pathway.
- The venom's mechanism is largely independent of the alternative pathway and serum cofactors.
- These findings provide insights into the immunomodulatory effects of Loxosceles reclusa venom.